Khan Fareena, Khan Muhammad Taimur, Zaman Sana, Mujtaba Sadaf, Batool Aeliya, Ghanghro Zohra, Anwar Adnan, Hashmi Atif A
Anaesthesia, Baqai Medical University, Karachi, PAK.
Family Medicine, Standish Medical Practice, Standish, GBR.
Cureus. 2023 Mar 10;15(3):e36005. doi: 10.7759/cureus.36005. eCollection 2023 Mar.
Objectives Vaccinations protect against disease through various ways, but the process of developing immunity might result in side effects. This study determined the immediate side effects of coronavirus disease 2019 (COVID-19) vaccination among patients with diabetes and non-diabetic participants. Methods This multi-center, cross-sectional study was conducted in multiple hospitals in Karachi, Pakistan. The duration of the study was six months, from March 1, 2022, to August 31, 2022. A total of 1150 participants who received one of the COVID-19 vaccines, for instance, Sinopharm, AstraZeneca, Sinovac, and Pfizer (double or booster doses) were included in the study and allocated into two groups: diabetics (n=540) and non-diabetics (n=610). The chi-square test was used to compare the frequency of side effects between diabetic and non-diabetic participants. The association between means of demographic variables such as age and weight was compared using an independent t-test. Results The study findings showed that the mean age of the group with diabetes was 46.73±14.98 years and that of the non-diabetic group was 44.01±14.80 years with a significant difference between them (p=0.002). The majority of participants, 187 (34.6%) patients with diabetes received Pfizer, while 234 (38.4%) non-diabetic participants received Sinovac. Following the first dose, side effects were higher in patients with diabetes. Burning at the injection site, fever, and pain were the most commonly reported side effects in patients with diabetes following the first dose. Additionally, following the second dose, burning at the injection site, muscular pain, fever, and pain were the most commonly observed side effects, with a significant association among diabetic and non-diabetic participants (p<0.001). Conclusion Diabetes is a prevalent comorbidity in individuals infected with COVID-19, and patients with diabetes report more side effects from immunization than non-diabetic participants. The most commonly reported side effects of the vaccine in diabetic participants were observed to be burning at the injection site, fever, muscle and joint pain, and swelling at the injection site. Additionally, participants with and without diabetes reported feeling satisfied with their vaccines.
目的 疫苗通过多种方式预防疾病,但产生免疫的过程可能会导致副作用。本研究确定了2019冠状病毒病(COVID-19)疫苗接种在糖尿病患者和非糖尿病参与者中的即时副作用。方法 本多中心横断面研究在巴基斯坦卡拉奇的多家医院进行。研究持续时间为6个月,从2022年3月1日至2022年8月31日。共有1150名接种了COVID-19疫苗(如国药集团、阿斯利康、科兴和辉瑞疫苗,双剂量或加强剂量)的参与者被纳入研究,并分为两组:糖尿病患者(n = 540)和非糖尿病患者(n = 610)。采用卡方检验比较糖尿病和非糖尿病参与者之间副作用的频率。使用独立t检验比较年龄和体重等人口统计学变量均值之间的关联。结果 研究结果显示,糖尿病组的平均年龄为46.73±14.98岁,非糖尿病组为44.01±14.80岁,两组之间存在显著差异(p = 0.002)。大多数参与者中,187名(34.6%)糖尿病患者接种了辉瑞疫苗,而234名(38.4%)非糖尿病参与者接种了科兴疫苗。首剂接种后,糖尿病患者的副作用发生率更高。注射部位烧灼感、发热和疼痛是糖尿病患者首剂接种后最常报告的副作用。此外,第二剂接种后,注射部位烧灼感、肌肉疼痛、发热和疼痛是最常观察到的副作用,糖尿病和非糖尿病参与者之间存在显著关联(p < 0.001)。结论 糖尿病是感染COVID-19个体中的一种常见合并症,糖尿病患者报告的免疫接种副作用比非糖尿病参与者更多。在糖尿病参与者中,疫苗最常报告的副作用是注射部位烧灼感、发热、肌肉和关节疼痛以及注射部位肿胀。此外,有糖尿病和无糖尿病的参与者都对他们接种的疫苗感到满意。